Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 10/2019

01-10-2019 | Care | Research Article

Results of a nationwide survey on multidisciplinary teams on thyroid cancer in Spain

Authors: J. J. Díez, J. C. Galofré, A. Oleaga, E. Grande, M. Mitjavila, P. Moreno

Published in: Clinical and Translational Oncology | Issue 10/2019

Login to get access

Abstract

Aim

There is an important lack of knowledge as to the functioning of multidisciplinary teams on thyroid cancer in current clinical practice. We aimed to retrieve data on the composition, structure, and procedures developed by the multidisciplinary units of thyroid cancer in Spain.

Methods

A nationwide survey consisting of questions about composition, structure, and functioning of multidisciplinary teams was designed. It was available online from November 15, 2017 to February 15, 2018.

Results

Seventy-two multidisciplinary units responded to our survey. Of these, 15 (20.8%) focused only in thyroid cancer, while 57 (79.2%) included other endocrine disorders or non-endocrine tumors. The median (interquartile range) of members of the teams was 11 (9–14). The most frequent medical specialties in the units were endocrinology (100%), surgery (94.4%), pathology (80.6%), radiology (75.0%), nuclear medicine (73.6%), and medical oncology (55.6%). The annual number of patients reviewed by the teams was 40 (20–74). 56.9% of the multidisciplinary teams have elaborated clinical protocols for local use. Apart from clinical case discussions in the meetings, 45.8% of the units included educational activities and 36.1% research subjects. Quality indicators were developed by 22% of the teams.

Conclusions

These results suggest that there are some hopeful signs that international recommendations of having multidisciplinary approach to patients with thyroid cancer are being followed in Spain. This gives us the opportunity to proceed with further studies to analyze the real impact of this high standard of care on patient outcomes.
Literature
1.
Díez JJ, Grande E, Alonso T, Iglesias P. Abordaje multidisciplinar en el diagnóstico y tratamiento de pacientes con tumores endocrinos. Med Clín (Barc). 2015;145:36–41.CrossRef
2.
Lamb BW, Taylor C, Lamb JN, Strickland SL, Vicent C, Green JSA, et al. Facilitators and barriers to teamworking and patient centeredness in multidisciplinary cancer teams: findings of a national study. Ann Surg Oncol. 2013;20:1408–16.CrossRefPubMed
3.
Taylor C, Munro AJ, Glynne-Jones R, Griffith C, Trevatt P, Richards M, et al. Multidisciplinary team working in cancer: What is the evidence? BMJ. 2010;340:c951.CrossRefPubMed
4.
Tamagno G, Sheahan K, Skehan SJ, Geoghegan JG, Fennelly D, Collins CD, et al. Initial impact of a systematic multidisciplinary approach on the management of patients with gastroenteropancreatic neuroendocrine tumor. Endocrine. 2013;44:504–9.CrossRefPubMed
5.
Pawlik TM, Laheru D, Hruban RH, Coleman J, Wolfgang CL, Campbell K, et al. Evaluating the impact of a single-day multidisciplinary clinic on the management of pancreatic cancer. Ann Surg Oncol. 2008;15:2081–8.CrossRefPubMedPubMedCentral
6.
Horvath LE, Yordan E, Malhotra D, Leyva I, Bortel K, Schalk D, et al. Multidisciplinary care in the oncology setting: historical perspective and data from lung and gynecology multidisciplinary clinics. J Oncol Pract. 2010;6:e21–6.CrossRefPubMedPubMedCentral
7.
Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, et al. Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers. J Oncol Pract. 2012;8:e1s–5s.CrossRefPubMedPubMedCentral
8.
European Partnership Action Against Cancer consensus group, Borras JM, Albreht T, Audisio R, Briers E, Casali P, et al. Policy statement on multidisciplinary cancer care. Eur J Cancer. 2014;50:475–80.CrossRef
9.
Díez JJ, Galofré JC, Oleaga A, Grande E, Mitjavila M, Moreno P, et al. Declaración de consenso para la acreditación de unidades multidisciplinares en cáncer de tiroides. Endocrinol Nutr. 2016;63:e1–15.CrossRefPubMed
10.
11.
12.
13.
Wright FC, De Vito C, Langer B, Hunter A. Multidisciplinary cancer conferences: a ystematic review and development of practice standards. Eur J Cancer. 2007;43:1002–10.CrossRefPubMed
14.
Perros P, Boelaert K, Colley S, Evans C, Evans RM, Gerrard BG, et al. Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf). 2014;81(Suppl 1):1–122.CrossRef
15.
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133.CrossRefPubMedPubMedCentral
16.
Díez JJ, Oleaga A, Álvarez-Escolá C, Martín T, Galofré JC. Grupo de Trabajo de Cáncer de Tiroides de la Sociedad Española de Endocrinología y Nutrición. Guía clínica para el manejo de pacientes con carcinoma diferenciado de tiroides de bajo riesgo. Endocrinol Nutr. 2015;62:e57–72.CrossRefPubMed
17.
Sarkar S, Arora S, Lamb B, Green J, Sevdalis N, Darzi A. Case review in urology multidisciplinary team meetings: what members think of its functioning. J Clin Urol. 2014;7:394–402.CrossRef
18.
Lamb B, Jalil R, Sevdalis N, Vincent C, Green J. Strategies to improve the efficiency and utility of multidisciplinary team meetings in urology cancer care: a survey study. BMC Health Serv Res. 2014;14:377.CrossRefPubMedPubMedCentral
19.
Sundi D, Cohen JE, Cole AP, Neuman BP, Cooper J, Faisal FA, et al. Establishment of a new prostate cancer multidisciplinary clinic: format and initial experience. Prostate. 2015;75:191–9.CrossRefPubMed
20.
Kelly SL, Jackson JE, Hickey BE, Szallasi FG, Bond CA. Multidisciplinary clinic care improves adherence to best practice in head and neck cancer. Am J Otolaryngol. 2013;34:57–60.CrossRefPubMed
21.
Korman H, Lanni T, Shah C, Parslow J, Tull J, Ghilezan M, et al. Impact of a prostate multidisciplinary clinic program on patient treatment decisions and on adherence to NCCN guidelines: the William Beaumont Hospital experience. Am J Clin Oncol. 2013;20:778–84.
22.
Keating NL, Landrum MB, Lamont EB, Bozeman SR, Shulman LN, McNeil BJ. Tumor boards and the quality of cancer care. J Natl Cancer Inst. 2013;105:113–21.CrossRefPubMedPubMedCentral
23.
Lamb BW, Green JS, Benn J, Brown KF, Vincent CA, Sevdalis N. Improving decision making in multidisciplinary tumor boards: prospective longitudinal evaluation of a multicomponent intervention for 1,421 patients. J Am Coll Surg. 2013;217:412–20.CrossRefPubMed
24.
Henry M, Frenkiel S, Chartier G, MacDonald C, Payne RJ, Black JM, et al. Thyroid cancer patients receiving an interdisciplinary team-based approach (ITCA-ThyCa) appear to display better outcomes: program evaluation results indicating a need for further integrated care and support. Psychooncology. 2018;27:937–45.CrossRefPubMed
25.
Lamb BW, Brown KF, Nagpal K, Vincent C, Green JSA, Sevdalis N. Quality of care management decisions by multidisciplinary cancer teams: a systematic review. Ann Surg Oncol. 2011;18:2116–25.CrossRefPubMed
26.
McCarthy M, Datta P, Khachatryan A, Coleman MP, Rachet B. Would compliance with cancer care standards improve survival for breast, colorectal and lung cancers? J Epidemiol Community Health. 2008;62:650–4.CrossRefPubMed
27.
28.
Tree AC, Harding V, Bhangu A, Krishnasamy V, Morton D, Stebbing J, et al. The need for multidisciplinarity in specialist training to optimize future patient care. Nat Rev Clin Oncol. 2017;14:508–17.CrossRefPubMed
29.
Pillay B, Wootten AC, Crowe H, Corcoran N, Tran B, Bowden P, et al. The impact of multidisciplinary team meetings on patients assessment, management and outcomes in oncology settings: a systematic review of the literature. Cancer Treat Rev. 2016;42:56–72.CrossRefPubMed
30.
31.
Chinai N, Bintcliffe F, Armstrong EM, Teape J, Jones BM, Hosie KB. Does every patient need to be discussed at a multidisciplinary team meeting? Clin Radiol. 2013;68:780–4.CrossRefPubMed
Metadata
Title
Results of a nationwide survey on multidisciplinary teams on thyroid cancer in Spain
Authors
J. J. Díez
J. C. Galofré
A. Oleaga
E. Grande
M. Mitjavila
P. Moreno
Publication date
01-10-2019
Publisher
Springer International Publishing
Published in
Clinical and Translational Oncology / Issue 10/2019
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-019-02056-4

Other articles of this Issue 10/2019

Clinical and Translational Oncology 10/2019 Go to the issue

Special Article

Recommendations for follow-up of colorectal cancer survivors

Research Article

Data from real world to evaluate the efficacy of osimertinib in non-small cell lung cancer patients with central nervous system metastasis

Research Article

Prognostic factors and survival in Ewing’s sarcoma treated by limb salvage surgery

Research Article

Multiple sclerosis outcomes after cancer immunotherapy

Research Article

Expression of PDK1 in malignant pheochromocytoma as a new promising potential therapeutic target

Research Article

Mitotic rate as an important prognostic factor in cutaneous malignant melanoma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits